FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Convatecs Extracellular Matrix Wound Care Cleared

FDA cleared a Convatec 510(k) for its InnovaMatrix PD particulate placental extracellular matrix medical device for wound management.

latest-news-card-1
Human Drugs

Panel Meeting Nixed on OTC Opioid Reversal Agent

Federal Register notice: FDA cancels for undisclosed reasons a 3/20 joint meeting of the Nonprescription Drugs Advisory Committee and Anesthetic and A...

latest-news-card-1
Human Drugs

FDA Clears Bigfoot Bio Android Diabetes App

FDA clears a Bigfoot Biomedical 510(k) for the Android version of the Bigfoot Unity Mobile App, which is a part of the Bigfoot Unity Diabetes Manageme...

latest-news-card-1
Medical Devices

Noah Medicals Robotic Bronchoscopy Device Cleared

FDA clears a Noah Medical 510(k) for the Galaxy System, a robotic-navigated bronchoscopy device and accessories that are intended to provide bronchosc...

latest-news-card-1
Human Drugs

CDER 2022 Drug Safety Priorities Report Out

FDA publishes the CDER Drug Safety 2002 Priorities Report reviewing the many drug safety activities the Center undertook in 2022.

latest-news-card-1
Human Drugs

FDA, FTC Advancing Biologic Competition

CDER director Patrizia Cavazzoni describes how FDA and FTC are working collaboratively to increase competition for biologic products.

latest-news-card-1

Drug, Device Recalls Shoot Up in 2022: Report

The Sedgwick 2022 recall report says both drug and medical device recall events surged higher in 2022, with drugs outpacing devices.

latest-news-card-1
Human Drugs

8 Observations in Cipla FDA-483

FDA releases the form FDA-483 with eight observations from an inspection at the Madhya, Pradesh, India-based Cipla facility that manufactures sterile ...

latest-news-card-1
Medical Devices

Many Deficiencies in Musk Neuralink Brain Chip: FDA

A Reuters investigative report relying on anonymous sources says FDA has rejected an application from Elon Musks Neuralink to open human trials of its...

latest-news-card-1
Human Drugs

Bill to Restrict REMS from Delaying Competition

A Senate bipartisan bill aims to close a loophole that pharmaceutical companies can exploit to block drug competition, including generic drugs.